Acetylsalicylic acid Recruiting Phase 3 Trials for Cardioembolic Stroke / Nonvalvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02181361The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke